GENinCode (LON:GENI – Get Free Report) posted its quarterly earnings results on Monday. The company reported GBX (2.08) earnings per share for the quarter, Digital Look Earnings reports. The company had revenue of GBX 308 million for the quarter. GENinCode had a negative net margin of 170.49% and a negative return on equity of 262.16%.
GENinCode Price Performance
GENI opened at GBX 1 on Tuesday. The firm has a market cap of £7.25 million, a P/E ratio of -0.43 and a beta of 0.59. The firm has a 50-day moving average of GBX 1.13 and a 200 day moving average of GBX 1.54. The company has a debt-to-equity ratio of 7.17, a quick ratio of 15.89 and a current ratio of 2.80. GENinCode has a fifty-two week low of GBX 0.90 and a fifty-two week high of GBX 5.50.
About GENinCode
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.
Recommended Stories
- Five stocks we like better than GENinCode
- Walmart’s No. 2 Ranking Hides a Digital Transformation Story
- Campbell’s Soup Stock: Deep Value and a 7% Dividend Yield
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
